Diabetes OD > Disease Management > T2DM > Metabolic Control > Anti-Hyperglycemic and Anti-Apoptotic Agents > Incretin Hormones > Incretin Mimetics > Exenatide > Effectivity of Exenatide Therapy > Effectivity after Metformin Therapy	Display all items Journal Articles Discussion Articles Comments Discussions Conferences/Workshops Availabilities Grants/Funds Information/News

(Journal Article): Effects of exenatide (exendin-4) on glycemic con-trol and weight over 30 weeks in metformin-treated patients with type 2 diabetes.
 
DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD
 
IN: Diabetes Care 2005; 28(5):1092-1100
Impact Factor(s) of Diabetes Care: 7.071 (2004), 7.501 (2003), 5.477 (2002), 5.404 (2001)

ABSTRACT: OBJECTIVE: This study evaluates the ability of the incretin mimetic exenatide (exendin-4) to improve glycemic control in patients with type 2 diabetes failing to achieve glycemic c... Click HERE for details

(Journal Article): Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.
 
Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD
 
IN: Diabetes Care 2005; 28(5):1083-1091
Impact Factor(s) of Diabetes Care: 7.071 (2004), 7.501 (2003), 5.477 (2002), 5.404 (2001)

ABSTRACT: OBJECTIVE: This study evaluated the effects of exenatide, a novel incretin mimetic, in hyperglycemic patients with type 2 diabetes unable to achieve glycemic control with metformin... Click HERE for details